摘要
Ever since the first percutaneous transluminal coronary angioplasty (PTCA) was completed successfully by Gruentzig in 1977, postoperational restenosis (RS) has been puzzling constantly the progress of percutaneous coronary intervention (PCI), and it is known as the Achilles Heel of PCI. In a certain sense, the development history of PCI is also the history of continually overcoming RS.
Ever since the first percutaneous transluminal coronary angioplasty (PTCA) was completed successfully by Gruentzig in 1977, postoperational restenosis (RS) has been puzzling constantly the progress of percutaneous coronary intervention (PCI), and it is known as the Achilles Heel of PCI. In a certain sense, the development history of PCI is also the history of continually overcoming RS.